Subscribe 600$/product give away!
Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ALDURAZYME- laronidase injection, solution, concentrate

  1. Patient Information
  2. Aldurazyme Is Manufactured By:
  3. Aldurazyme Is Distributed By:

Patient Information 

Patients should be counseled that allergic reactions may occur during ALDURAZYME treatment, including life-threatening anaphylaxis. Premedication and reduction of infusion rate may alleviate those allergic reactions associated with the infusion. The appropriate length of postinfusion monitoring is to be determined by the treating physician based on the individual patient s clinical status and infusion history [seeWarnings and Precautions (5)].

Patients should be advised to report any adverse reactions experienced while on ALDURAZYME treatment.

It is unknown how ALDURAZYME affects women during pregnancy, labor and delivery or while nursing, as no adequate and well-controlled clinical studies have been conducted in these patient populations [seeUse in Specific Populations (8)].

The full benefits of ALDURAZYME may not be evident for several months to years of treatment. To maintain treatment benefit, ALDURAZYME should be administered on a weekly basis as indicated.

Patients should be informed that a registry for MPS I patients has been established in order to better understand the MPS I disease, and to track clinical outcomes of patients with MPS I over time. Patients should be encouraged to participate and advised that their participation is voluntary and may involve long-term follow-up. Information regarding the registry program may be found at or by calling 1 800 745 4447 ext. 15500.

Aldurazyme Is Manufactured By: 

BioMarin Pharmaceutical Inc.

Novato, CA 94949

US License Number 1649

Aldurazyme Is Distributed By: 

Genzyme Corporation

Cambridge, MA 02142

1-800-745-4447 (phone)

ALDURAZYMEis a registered trademark of BioMarin/Genzyme LLC. All rights reserved.

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: